A. Vicari

发表

Redirecting in vivo elicited tumor infiltrating macrophages and dendritic cells towards tumor rejection.

G. Trinchieri, M. Colombo, C. Guiducci, 2005, Cancer research.

Identification of RNA Sequence Motifs Stimulating Sequence-Specific TLR8-Dependent Immune Responses1

Marion Jurk, G. Mutwiri, A. Vicari, 2008, The Journal of Immunology.

C. Caux, A. Vicari, 2002, Cytokine & growth factor reviews.

MyD88-Dependent and -Independent Murine Cytomegalovirus Sensing for IFN-α Release and Initiation of Immune Responses In Vivo1

S. Akira, G. Trinchieri, P. Kastner, 2005, The Journal of Immunology.

A role for BP-3/BST-1 antigen in early T cell development.

A. Zlotnik, A. Bean, A. Vicari, 1996, International immunology.

Interleukin 7 induces preferential expansion of V beta 8.2+CD4-8- and V beta 8.2+CD4+8- murine thymocytes positively selected by class I molecules

A. Herbelin, A. Vicari, C. Pénit, 1994, The Journal of experimental medicine.

REGULATION OF DENDRITIC CELL RECRUITMENT BY CHEMOKINES

C. Caux, M. Dieu-Nosjean, A. Vicari, 2002, Transplantation.

Discovery and characterization of a novel humanized anti-IL-15 antibody and its relevance for the treatment of refractory celiac disease and eosinophilic esophagitis

A. Schoepfer, A. Straumann, H. Simon, 2017, mAbs.

The mysterious Eosinophilic Esophagitis still keeps some secrets

A. Vicari, 2017 .

Strategies for use of IL‐10 or its antagonists in human disease

C. Hawrylowicz, A. O’Garra, A. Vicari, 2008, Immunological reviews.

Paclitaxel reduces regulatory T cell numbers and inhibitory function and enhances the anti-tumor effects of the TLR9 agonist PF-3512676 in the mouse

D. C. Hanson, A. Vicari, A. Krieg, 2009, Cancer Immunology, Immunotherapy.

A molecular analysis of NKT cells: identification of a class‐I restricted T cell‐associated molecule (CRTAM)

N. Copeland, D. Gilbert, N. Jenkins, 2000, Journal of leukocyte biology.

TECK: a novel CC chemokine specifically expressed by thymic dendritic cells and potentially involved in T cell development.

N. Copeland, D. Gilbert, N. Jenkins, 1997, Immunity.

Signal requirements for activation of leukaemic T cells from a chronic lymphocytic leukaemia (T‐CLL)

A. Villa, M. Ferrarini, L. Inverardi, 1990, Clinical and experimental immunology.

and Initiation of Immune Responses In Vivo Release α Cytomegalovirus Sensing for IFN- MyD88-Dependent and -Independent Murine

S. Akira, G. Trinchieri, A. Paquin, 2014 .

IL-7 reverses NK1+ T cell-defective IL-4 production in the non-obese diabetic mouse.

A. Herbelin, J. Bach, A. Vicari, 1996, International immunology.

Type I interferon dependence of plasmacytoid dendritic cell activation and migration

G. Trinchieri, A. Boonstra, A. O’Garra, 2005, The Journal of experimental medicine.

Mouse γδ TCR+NK1.1+ thymocytes specifically produce interleukin‐4, are major histocompatibility complex class I independent, and are developmentally related to αβ TCR+NK1.1+ thymocytes

A. Zlotnik, A. O’Garra, P. Openshaw, 1996 .

NK1.1+ T cells from IL-7-deficient mice have a normal distribution and selection but exhibit impaired cytokine production.

A. Zlotnik, A. Herbelin, A. Vicari, 1996, International immunology.

Mouse NK1.1+ T cells: a new family of T cells.

A. Zlotnik, A. Vicari, Alain Vicari, 1996, Immunology today.

MHC class I-selected CD4-CD8-TCR-alpha beta+ T cells are a potential source of IL-4 during primary immune response.

A. Herbelin, A. Vicari, J. Gombert, 1995, Journal of immunology.

Dendritic cell biology and regulation of dendritic cell trafficking by chemokines

C. Caux, A. Zlotnik, B. Homey, 2009, Springer Seminars in Immunopathology.

Antitumor Effects of the Mouse Chemokine 6Ckine/SLC Through Angiostatic and Immunological Mechanisms1

C. Caux, A. Zlotnik, A. Vicari, 2000, The Journal of Immunology.

Inﬂammatory Protein 3 a Is Expressed at Inﬂamed Epithelial Surfaces and Is the Most Potent Chemokine Known in Attracting Langerhans Cell Precursors By

C. Caux, D. Schmitt, A. Zlotnik, 2000 .

Cytokines and Chemokines in T-Cell Development

A. Zlotnik, A. Vicari, M. Capone, 1998 .

Compositions de ligands tlr et d'antiviraux

Robert L. Bratzler, A. Vicari, J. Vollmer, 2007 .

Identification of a Novel CC Chemokine ( CCL 28 ) which binds CCR 10 ( GPR 2 )

Kathleen M. Smith, T. Mcclanahan, N. Copeland, 2000 .

Regulation of the trafficking of tumour-infiltrating dendritic cells by chemokines.

I. Treilleux, S. Lebecque, A. Vicari, 2004, Seminars in cancer biology.

Mouse gamma delta TCR+NK1.1+ thymocytes specifically produce interleukin-4, are major histocompatibility complex class I independent, and are developmentally related to alpha beta TCR+NK1.1+ thymocytes.

A. Zlotnik, A. O’Garra, P. Openshaw, 1996, European Journal of Immunology.

Anti-MMP-9 Antibody: A Promising Therapeutic Strategy for Treatment of Inflammatory Bowel Disease Complications with Fibrosis

G. Rogler, M. Hausmann, L. Goffin, 2016, Inflammatory bowel diseases.

Interleukln 7 Induces Preferential Expansion of V 38 . 2 + CD 4-8-and V 38 . 2 + CD 4 + 8-Murine Thymocytes Positively Selected by Class I Molecules

A. Vicari, C. Pénit, L. Moraes, 2003 .

Requirement of IL-7 for IL-4-producing potential of MHC class I-selected CD4 –CD8– TCRαβF thymocytes

A. Herbelin, A. Vicari, J. Gombert, 1997 .

Requirement of IL-7 for IL-4-producing potential of MHC class I-selected CD4-CD8-TCR alpha beta+ thymocytes.

A. Herbelin, A. Vicari, J. Gombert, 1997, International immunology.

TLR 8-Dependent Immune Responses Stimulating Sequence-Specific Identification of RNA Sequence Motifs

Marion Jurk, G. Mutwiri, A. Vicari, 2008 .

In vivo manipulation of dendritic cell migration and activation to elicit antitumour immunity.

G. Trinchieri, M. Colombo, C. Caux, 2004, Novartis Foundation symposium.

Selective Recruitment of Immature and Mature Dendritic Cells by Distinct Chemokines Expressed in Different Anatomic Sites

C. Caux, A. Zlotnik, S. Lebecque, 1998, The Journal of experimental medicine.

Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology

Marc Dalod, Isabelle Durand, G. Trinchieri, 2001, Nature Immunology.

Macrophage Inflammatory Protein 3α Is Expressed at Inflamed Epithelial Surfaces and Is the Most Potent Chemokine Known in Attracting Langerhans Cell Precursors

C. Caux, D. Schmitt, A. Zlotnik, 2000, The Journal of experimental medicine.

CTACK, a skin-associated chemokine that preferentially attracts skin-homing memory T cells.

N. Copeland, N. Jenkins, A. Zlotnik, 1999, Proceedings of the National Academy of Sciences of the United States of America.

Regulation of dendritic cell trafficking: a process that involves the participation of selective chemokines

C. Caux, S. Lebecque, M. Dieu-Nosjean, 1999, Journal of leukocyte biology.

Identification through bioinformatics of two new macrophage proinflammatory human chemokines: MIP-3alpha and MIP-3beta.

T. Mcclanahan, K. Franz-Bacon, A. Zlotnik, 1997, Journal of immunology.

Identification of a novel selD homolog from eukaryotes, bacteria, and archaea: is there an autoregulatory mechanism in selenocysteine metabolism?

N. Copeland, D. Gilbert, N. Jenkins, 1996, Proceedings of the National Academy of Sciences of the United States of America.

Pitfalls of vaccinations with WT1-, Proteinase3- and MUC1-derived peptides in combination with MontanideISA51 and CpG7909

P. Greenberg, A. Vicari, H. Davis, 2010, Cancer Immunology, Immunotherapy.

Sequential involvement of CCR2 and CCR6 ligands for immature dendritic cell recruitment: possible role at inflamed epithelial surfaces

C. Caux, B. Homey, A. Vicari, 2002, European journal of immunology.

Identification of a Novel Chemokine (CCL28), which Binds CCR10 (GPR2)*

Kathleen M. Smith, T. Mcclanahan, N. Copeland, 2000, The Journal of Biological Chemistry.

Dendritic cells rapidly recruited into epithelial tissues via CCR6/CCL20 are responsible for CD8+ T cell crosspriming in vivo.

J. Sirard, C. Caux, S. Lira, 2006, Immunity.

What's new in the field of cancer vaccines?

A. Vicari, T. Renno, S. Saeland, 2003, Cellular and Molecular Life Sciences CMLS.

Safety, Pharmacokinetics and Immune Effects in Normal Volunteers of CPG 10101 (ACTILON™), an Investigational Synthetic Toll-like Receptor 9 Agonist

A. Vicari, A. Krieg, H. Davis, 2007, Antiviral therapy.

Cladribine inhibits cytokine secretion by T cells independently of deoxycytidine kinase activity

A. Vicari, Bruno Laugel, D. Bruniquel, 2011, Journal of Neuroimmunology.

Interleukin‐10 in viral diseases and cancer: exiting the labyrinth?

G. Trinchieri, A. Vicari, 2004, Immunological reviews.

Immunostimulatory potential of silencing RNAs can be mediated by a non-uridine-rich toll-like receptor 7 motif.

Marion Jurk, A. Vicari, A. Krieg, 2011, Nucleic acid therapeutics.

Tumour escape from immune surveillance through dendritic cell inactivation.

Christophe Caux, G. Trinchieri, C. Caux, 2002, Seminars in cancer biology.

Reversal of Tumor-induced Dendritic Cell Paralysis by CpG Immunostimulatory Oligonucleotide and Anti–Interleukin 10 Receptor Antibody

G. Trinchieri, M. Colombo, C. Caux, 2002, The Journal of experimental medicine.

Anticorps anti-il-15

A. Vicari, O. Leger, 2015 .

Distinct and overlapping roles of interleukin-10 and CD25+ regulatory T cells in the inhibition of antitumor CD8 T-cell responses.

G. Trinchieri, C. Caux, A. Vicari, 2005, Cancer research.

Lipid-derived nanoparticles for immunostimulatory RNA adjuvant delivery

Michael S. Goldberg, Daniel G. Anderson, Jianzhu Chen, 2012, Proceedings of the National Academy of Sciences.

A novel CD45RA+CD4+ transient thymic subpopulation in MRL-lpr/lpr mice: its relation to non-proliferating CD4-CD8-CD45RA+ tumor cells.

A. Vicari, C. Pénit, F. Vasseur, 1993, International immunology.

Characterization of a novel CC chemokine, HCC-4, whose expression is increased by interleukin-10.

A. Zlotnik, A. Vicari, J. Hedrick, 1998, Blood.

pre-clinical Proof-of-concept Of Alx-0761, a Nanobody® Neutralizing Both Il-17a and F In a Cynomolgus Monkey Collagen Induced Arthritis Model. : 1287

A. Vicari, R. Grenningloh, L. Detalle, 2013 .

10th antibody industrial symposium: new developments in antibody and adoptive cell therapies

P. Martineau, T. Wurch, L. Álvarez-Vallina, 2023, mAbs.

Selective Recruitment of Immature and Mature Dendritic Cells by Distinct Chemokines Expressed in Different Anatomic Sites

C. Caux, A. Zlotnik, S. Lebecque, 1998, The Journal of experimental medicine.

Type I interferon dependence of plasmacytoid dendritic cell activation and migration

G. Trinchieri, A. Boonstra, A. O’Garra, 2005, The Journal of experimental medicine.